FOLD
Amicus Therapeutics Inc
$14.45
+0.07% (+$0.01)
Volume
2.31M
52W High
$14.46
52W Low
$5.51
Market Cap
$4.50B
What to Watch This Quarter
Based on historical dataConsensus EPS
$0.07
Whisper EPS
$0.08
15.0% above consensus
Last Quarter
--
Current Streak
4 Beats
Avg Surprise (4Q)
+80.99%
Next Earnings Report
Reports in 30 days
Price Chart
EPS History: Consensus vs Actual
Last 10 quartersPrice Movement Around Earnings
Q4 2025
Feb 25, 2026
1-Day:
-0.07%
5-Day:
+0.14%
Q4 2025
Feb 19, 2026
1-Day:
-0.07%
5-Day:
+0.07%
Q4 2025
Feb 18, 2026
1-Day:
+0.07%
5-Day:
+0.14%
Q3 2025
Nov 4, 2025
1-Day:
+2.22%
Revenue & Financial Performance
Revenue Whisper
$173.0M
TWN Proprietary Estimate
Last Quarter Revenue
$185.2M
+23.7% YoY
Gross Margin
84.6%
Net Margin: 0.9%
| Quarter | Revenue | YoY Growth | Gross Margin | Op Margin | Net Income |
|---|---|---|---|---|---|
| Q4'25 | $185.2M | +23.7% | 84.6% | 8.6% | $1.7M |
| Q3'25 | $169.1M | +19.5% | 87.4% | 20.3% | $17.3M |
| Q2'25 | $154.7M | +22.1% | 90.2% | -6.1% | -$24.4M |
| Q1'25 | $125.2M | +13.5% | 90.7% | -6.4% | -$21.7M |
| Q4'24 | $149.7M | +30.1% | 90.1% | 10.7% | $14.7M |
| Q3'24 | $141.5M | +36.7% | 90.6% | 15.3% | -$6.7M |
| Q2'24 | $126.7M | +34.0% | 91.1% | 11.8% | -$15.7M |
| Q1'24 | $110.4M | +28.0% | 87.7% | -25.1% | -$48.4M |
Company Information
Symbol
FOLD
Company
Amicus Therapeutics Inc
Market Cap
$4.50B
Next Earnings
May 7, 2026